ANALYSIS OF CATHEPSIN D FORMS AND THEIR CLINICAL IMPLICATIONS IN HUMAN PROSTATE CANCER
- 1 December 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (6 Part 1), 2223-2228
- https://doi.org/10.1016/s0022-5347(01)62300-0
Abstract
Conclusion This study demonstrates that expression and activity of Cat.D varies among prostate specimens. A greater expression of mature Cat.D with a higher catalytic activity in CAP specimens is the most notable difference from NML/BPH. Therefore, the differential expression/activity activity of Cat.D forms may be a useful indicator for assessing prostate cancer status.Keywords
This publication has 21 references indexed in Scilit:
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Cathepsin D and Epidermal Growth Factor Receptor Immunohistochemistry does not Predict Recurrence of Prostate Cancer in Patients Undergoing Radical ProstatectomyJournal of Urology, 1996
- Quantitative Immunohistochemical Determination of Cathepsin D Levels in Prostatic Carcinoma Biopsies:Correlation with Tumor Grade, Stage, PSA Level, and DNA Ploidy StatusAmerican Journal of Clinical Pathology, 1995
- The Clinical Usefulness of Prostate Specific Antigen: Update 1994Journal of Urology, 1994
- How to use prostate-specific antigenUrology, 1994
- The distribution of PSA, cathepsin-D, and pS2 in BPH and cancer of the prostateThe Prostate, 1992
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancerJournal of Steroid Biochemistry, 1989
- Biosynthesis of lysosomal endopeptidasesJournal of Cellular Biochemistry, 1989